Pharmafile Logo
Pharmafocus logo
Advanced Search

Amgen

Showing 15 posts of 216 posts found.

Amgen image

Amgen and Novartis start cancer immunotherapy push

January 7, 2015
Research and Development, Sales and Marketing Amgen, Caribou Biosciences, Intellia Therapeutics, Novartis, kite pharma

Amgen and Novartis have launched new licensing agreements with biotech companies that they hope will lead to the development of …

News
Sandoz image

Novartis biosimilar rivals Amgen offering

December 9, 2014
Sales and Marketing Amgen, Neupogen, Novartis, Sandoz, filgrastim, zarzio

An investigational biosimilar by Novartis’ generic pharma arm Sandoz has been found to have comparable safety and efficacy readings to …

News
Sanofi image

Sanofi showcases alirocumab at AHA

November 20, 2014
Sales and Marketing Amgen, PCSK9, Regeneron, Sanofi, aha, alirocumab, evolocumab

Sanofi and Regeneron released a battery of new Phase III data on their PCSK9 inhibitor alirocumab this week, reinforcing the …

News
Amgen image

Amgen submits next gen cholesterol drug

August 29, 2014
Sales and Marketing Amgen, FDA, PCSK9, Regeneron, Sanofi, statins

Amgen has put itself in pole position in the race to market the next generation of injectable statins known as …

News
amgen image

Amgen cancer drug fails key test

August 14, 2014
Sales and Marketing Amgen, Cancer, Kyprolis, myeloma

Amgen’s new rare cancer drug has failed in a late-stage trial just a year after the US biotech spent $10.4 …

News
Amgen HQ

Amgen to wield axe on 2,900 jobs

July 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, Prolia, job cuts

Amgen has announced this morning that it will make swingeing cuts in the US over the next two years as …

News
Amgen image

FDA breakthrough for Amgen

July 2, 2014
Research and Development, Sales and Marketing Amgen, BiTE antibody blinatumomab, FDA, all, leukaemia

Amgen has taken a major step down the road to getting its investigational cancer drug blinatumomab onto the market after …

News
dave_piacquad

Amgen names senior VP of Business Development

March 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, David Piacquad

Amgen has confirmed the appointment of David Piacquad to the new position of senior vice president of its Business Development …

Appointment
Amgen image

Success for Amgen’s ‘bad’ cholesterol injection

March 18, 2014
Research and Development, Sales and Marketing Amgen, LDL, PCSK9, evolocumab, hofh, tesla

An investigational PCSK9 Inhibitor from Amgen has reduced LDL-C (‘bad’ cholesterol) in patients suffering from a rare genetic disorder in …

News
Amgen image

Amgen melanoma vaccine shrinks tumours

March 17, 2014
Research and Development, Sales and Marketing Amgen, Cancer, Yervoy, melanoma, t-vec

Amgen’s investigational cancer vaccine T-vec has managed to shrink the size of advanced melanoma tumours in a late-stage trial. The …

News
Prolia image

ABPI worried about Prolia use

March 10, 2014
Sales and Marketing ABPI, Amgen, NHS, Xgeva

The ABPI has once again voiced concern that NHS patients in some areas of England are not getting access to …

News
Amgen image

Amgen commits $2.5 million to biotech educational grants

November 12, 2013
Research and Development, Sales and Marketing Amgen, EDC, Onyx, biotech, stem

The Amgen Foundation has announced $2.5 million in new grants for its science programme to aid schools in the US …

News
brian_mcnamee_amgen

Amgen promotes two senior executives

October 29, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen

Amgen has promoted two senior executives as Brian McNamee becomes executive vice president and Stuart Tross senior vice president. McNamee …

Appointment
amgen image

Amgen to open Chinese R&D centre

September 26, 2013
Research and Development, Sales and Marketing Amgen, China, R&D, Zhejiang

Amgen has signalled its intention to expand in China by announcing the opening of an R&D centre which will focus …

News
Amgen image

Amgen/Cytokinetics heart drug fails in clinical trial

September 3, 2013
Research and Development, Sales and Marketing Amgen, Novartis, cytokinetics, omecamtiv mecarbil

A new heart failure drug by Amgen and Cytokinetics has fallen short of its primary endpoint in a Phase II …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025